Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body's innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Regenerative medicine is defined as the process of replacing or "regenerating" human cells, tissues or organs to restore or establish normal function and has been called the "next evolution of medical treatments" and "the vanguard of 21st century healthcare" by the U.S. Department of Health and Human Services.
This report contains market size and forecasts of Regenerative Medicine in Global, including the following market information:
Global Regenerative Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Regenerative Medicine market was valued at 34340 million in 2021 and is projected to reach US$ 111830 million by 2028, at a CAGR of 18.4% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cell Therapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Regenerative Medicine include J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker, Allergan(Acelity), MiMedx Group, Organogenesis, Fujifilm Cellular Dynamics and Osiris Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Regenerative Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Regenerative Medicine Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Regenerative Medicine Market Segment Percentages, by Type, 2021 (%)
- Cell Therapy
- Tissue Engineering
- Biomaterial
- Other
Global Regenerative Medicine Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Regenerative Medicine Market Segment Percentages, by Application, 2021 (%)
- Dermatology
- Cardiovascular
- CNS
- Orthopedic
- Others
Global Regenerative Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Regenerative Medicine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- - US
- - Canada
- - Mexico
- Europe
- - Germany
- - France
- - U.K.
- - Italy
- - Russia
- - Nordic Countries
- - Benelux
- - Rest of Europe
- Asia
- - China
- - Japan
- - South Korea
- - Southeast Asia
- - India
- - Rest of Asia
- South America
- - Brazil
- - Argentina
- - Rest of South America
- Middle East & Africa
- - Turkey
- - Israel
- - Saudi Arabia
- - UAE
- - Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Regenerative Medicine revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Regenerative Medicine revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- J & J (DePuy Synthes)
- Medtronic
- Zimmer Biomet
- Stryker
- Allergan(Acelity)
- MiMedx Group
- Organogenesis
- Fujifilm Cellular Dynamics
- Osiris Therapeutics
- Vcanbio
- CCBC
- Cytori
- Celgene
- Vericel Corporation
- Guanhao Biotech
- Mesoblast
- AMAG Pharmaceuticals (CBR)
- ViaCord
- CordLife
- Integra LifeSciences
- Nuvasive
- Cook Biotech
- Japan Tissue Engineering
Regenerative Medicine Market - Global Outlook and Forecast 2022-2028
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Regenerative Medicine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Regenerative Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Regenerative Medicine Overall Market Size
2.1 Global Regenerative Medicine Market Size: 2021 VS 2028
2.2 Global Regenerative Medicine Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Regenerative Medicine Players in Global Market
3.2 Top Global Regenerative Medicine Companies Ranked by Revenue
3.3 Global Regenerative Medicine Revenue by Companies
3.4 Top 3 and Top 5 Regenerative Medicine Companies in Global Market, by Revenue in 2021
3.5 Global Companies Regenerative Medicine Product Type
3.6 Tier 1, Tier 2 and Tier 3 Regenerative Medicine Players in Global Market
3.6.1 List of Global Tier 1 Regenerative Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 Regenerative Medicine Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Regenerative Medicine Market Size Markets, 2021 & 2028
4.1.2 Cell Therapy
4.1.3 Tissue Engineering
4.1.4 Biomaterial
4.1.5 Other
4.2 By Type - Global Regenerative Medicine Revenue & Forecasts
4.2.1 By Type - Global Regenerative Medicine Revenue, 2017-2022
4.2.2 By Type - Global Regenerative Medicine Revenue, 2023-2028
4.2.3 By Type - Global Regenerative Medicine Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Regenerative Medicine Market Size, 2021 & 2028
5.1.2 Dermatology
5.1.3 Cardiovascular
5.1.4 CNS
5.1.5 Orthopedic
5.1.6 Others
5.2 By Application - Global Regenerative Medicine Revenue & Forecasts
5.2.1 By Application - Global Regenerative Medicine Revenue, 2017-2022
5.2.2 By Application - Global Regenerative Medicine Revenue, 2023-2028
5.2.3 By Application - Global Regenerative Medicine Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Regenerative Medicine Market Size, 2021 & 2028
6.2 By Region - Global Regenerative Medicine Revenue & Forecasts
6.2.1 By Region - Global Regenerative Medicine Revenue, 2017-2022
6.2.2 By Region - Global Regenerative Medicine Revenue, 2023-2028
6.2.3 By Region - Global Regenerative Medicine Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Regenerative Medicine Revenue, 2017-2028
6.3.2 US Regenerative Medicine Market Size, 2017-2028
6.3.3 Canada Regenerative Medicine Market Size, 2017-2028
6.3.4 Mexico Regenerative Medicine Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Regenerative Medicine Revenue, 2017-2028
6.4.2 Germany Regenerative Medicine Market Size, 2017-2028
6.4.3 France Regenerative Medicine Market Size, 2017-2028
6.4.4 U.K. Regenerative Medicine Market Size, 2017-2028
6.4.5 Italy Regenerative Medicine Market Size, 2017-2028
6.4.6 Russia Regenerative Medicine Market Size, 2017-2028
6.4.7 Nordic Countries Regenerative Medicine Market Size, 2017-2028
6.4.8 Benelux Regenerative Medicine Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Regenerative Medicine Revenue, 2017-2028
6.5.2 China Regenerative Medicine Market Size, 2017-2028
6.5.3 Japan Regenerative Medicine Market Size, 2017-2028
6.5.4 South Korea Regenerative Medicine Market Size, 2017-2028
6.5.5 Southeast Asia Regenerative Medicine Market Size, 2017-2028
6.5.6 India Regenerative Medicine Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Regenerative Medicine Revenue, 2017-2028
6.6.2 Brazil Regenerative Medicine Market Size, 2017-2028
6.6.3 Argentina Regenerative Medicine Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Regenerative Medicine Revenue, 2017-2028
6.7.2 Turkey Regenerative Medicine Market Size, 2017-2028
6.7.3 Israel Regenerative Medicine Market Size, 2017-2028
6.7.4 Saudi Arabia Regenerative Medicine Market Size, 2017-2028
6.7.5 UAE Regenerative Medicine Market Size, 2017-2028
7 Players Profiles
7.1 J & J (DePuy Synthes)
7.1.1 J & J (DePuy Synthes) Corporate Summary
7.1.2 J & J (DePuy Synthes) Business Overview
7.1.3 J & J (DePuy Synthes) Regenerative Medicine Major Product Offerings
7.1.4 J & J (DePuy Synthes) Regenerative Medicine Revenue in Global Market (2017-2022)
7.1.5 J & J (DePuy Synthes) Key News
7.2 Medtronic
7.2.1 Medtronic Corporate Summary
7.2.2 Medtronic Business Overview
7.2.3 Medtronic Regenerative Medicine Major Product Offerings
7.2.4 Medtronic Regenerative Medicine Revenue in Global Market (2017-2022)
7.2.5 Medtronic Key News
7.3 Zimmer Biomet
7.3.1 Zimmer Biomet Corporate Summary
7.3.2 Zimmer Biomet Business Overview
7.3.3 Zimmer Biomet Regenerative Medicine Major Product Offerings
7.3.4 Zimmer Biomet Regenerative Medicine Revenue in Global Market (2017-2022)
7.3.5 Zimmer Biomet Key News
7.4 Stryker
7.4.1 Stryker Corporate Summary
7.4.2 Stryker Business Overview
7.4.3 Stryker Regenerative Medicine Major Product Offerings
7.4.4 Stryker Regenerative Medicine Revenue in Global Market (2017-2022)
7.4.5 Stryker Key News
7.5 Allergan(Acelity)
7.5.1 Allergan(Acelity) Corporate Summary
7.5.2 Allergan(Acelity) Business Overview
7.5.3 Allergan(Acelity) Regenerative Medicine Major Product Offerings
7.5.4 Allergan(Acelity) Regenerative Medicine Revenue in Global Market (2017-2022)
7.5.5 Allergan(Acelity) Key News
7.6 MiMedx Group
7.6.1 MiMedx Group Corporate Summary
7.6.2 MiMedx Group Business Overview
7.6.3 MiMedx Group Regenerative Medicine Major Product Offerings
7.6.4 MiMedx Group Regenerative Medicine Revenue in Global Market (2017-2022)
7.6.5 MiMedx Group Key News
7.7 Organogenesis
7.7.1 Organogenesis Corporate Summary
7.7.2 Organogenesis Business Overview
7.7.3 Organogenesis Regenerative Medicine Major Product Offerings
7.7.4 Organogenesis Regenerative Medicine Revenue in Global Market (2017-2022)
7.7.5 Organogenesis Key News
7.8 Fujifilm Cellular Dynamics
7.8.1 Fujifilm Cellular Dynamics Corporate Summary
7.8.2 Fujifilm Cellular Dynamics Business Overview
7.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Major Product Offerings
7.8.4 Fujifilm Cellular Dynamics Regenerative Medicine Revenue in Global Market (2017-2022)
7.8.5 Fujifilm Cellular Dynamics Key News
7.9 Osiris Therapeutics
7.9.1 Osiris Therapeutics Corporate Summary
7.9.2 Osiris Therapeutics Business Overview
7.9.3 Osiris Therapeutics Regenerative Medicine Major Product Offerings
7.9.4 Osiris Therapeutics Regenerative Medicine Revenue in Global Market (2017-2022)
7.9.5 Osiris Therapeutics Key News
7.10 Vcanbio
7.10.1 Vcanbio Corporate Summary
7.10.2 Vcanbio Business Overview
7.10.3 Vcanbio Regenerative Medicine Major Product Offerings
7.10.4 Vcanbio Regenerative Medicine Revenue in Global Market (2017-2022)
7.10.5 Vcanbio Key News
7.11 CCBC
7.11.1 CCBC Corporate Summary
7.11.2 CCBC Business Overview
7.11.3 CCBC Regenerative Medicine Major Product Offerings
7.11.4 CCBC Regenerative Medicine Revenue in Global Market (2017-2022)
7.11.5 CCBC Key News
7.12 Cytori
7.12.1 Cytori Corporate Summary
7.12.2 Cytori Business Overview
7.12.3 Cytori Regenerative Medicine Major Product Offerings
7.12.4 Cytori Regenerative Medicine Revenue in Global Market (2017-2022)
7.12.5 Cytori Key News
7.13 Celgene
7.13.1 Celgene Corporate Summary
7.13.2 Celgene Business Overview
7.13.3 Celgene Regenerative Medicine Major Product Offerings
7.13.4 Celgene Regenerative Medicine Revenue in Global Market (2017-2022)
7.13.5 Celgene Key News
7.14 Vericel Corporation
7.14.1 Vericel Corporation Corporate Summary
7.14.2 Vericel Corporation Business Overview
7.14.3 Vericel Corporation Regenerative Medicine Major Product Offerings
7.14.4 Vericel Corporation Regenerative Medicine Revenue in Global Market (2017-2022)
7.14.5 Vericel Corporation Key News
7.15 Guanhao Biotech
7.15.1 Guanhao Biotech Corporate Summary
7.15.2 Guanhao Biotech Business Overview
7.15.3 Guanhao Biotech Regenerative Medicine Major Product Offerings
7.15.4 Guanhao Biotech Regenerative Medicine Revenue in Global Market (2017-2022)
7.15.5 Guanhao Biotech Key News
7.16 Mesoblast
7.16.1 Mesoblast Corporate Summary
7.16.2 Mesoblast Business Overview
7.16.3 Mesoblast Regenerative Medicine Major Product Offerings
7.16.4 Mesoblast Regenerative Medicine Revenue in Global Market (2017-2022)
7.16.5 Mesoblast Key News
7.17 AMAG Pharmaceuticals (CBR)
7.17.1 AMAG Pharmaceuticals (CBR) Corporate Summary
7.17.2 AMAG Pharmaceuticals (CBR) Business Overview
7.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Major Product Offerings
7.17.4 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue in Global Market (2017-2022)
7.17.5 AMAG Pharmaceuticals (CBR) Key News
7.18 ViaCord
7.18.1 ViaCord Corporate Summary
7.18.2 ViaCord Business Overview
7.18.3 ViaCord Regenerative Medicine Major Product Offerings
7.18.4 ViaCord Regenerative Medicine Revenue in Global Market (2017-2022)
7.18.5 ViaCord Key News
7.19 CordLife
7.19.1 CordLife Corporate Summary
7.19.2 CordLife Business Overview
7.19.3 CordLife Regenerative Medicine Major Product Offerings
7.19.4 CordLife Regenerative Medicine Revenue in Global Market (2017-2022)
7.19.5 CordLife Key News
7.20 Integra LifeSciences
7.20.1 Integra LifeSciences Corporate Summary
7.20.2 Integra LifeSciences Business Overview
7.20.3 Integra LifeSciences Regenerative Medicine Major Product Offerings
7.20.4 Integra LifeSciences Regenerative Medicine Revenue in Global Market (2017-2022)
7.20.5 Integra LifeSciences Key News
7.21 Nuvasive
7.21.1 Nuvasive Corporate Summary
7.21.2 Nuvasive Business Overview
7.21.3 Nuvasive Regenerative Medicine Major Product Offerings
7.21.4 Nuvasive Regenerative Medicine Revenue in Global Market (2017-2022)
7.21.5 Nuvasive Key News
7.22 Cook Biotech
7.22.1 Cook Biotech Corporate Summary
7.22.2 Cook Biotech Business Overview
7.22.3 Cook Biotech Regenerative Medicine Major Product Offerings
7.22.4 Cook Biotech Regenerative Medicine Revenue in Global Market (2017-2022)
7.22.5 Cook Biotech Key News
7.23 Japan Tissue Engineering
7.23.1 Japan Tissue Engineering Corporate Summary
7.23.2 Japan Tissue Engineering Business Overview
7.23.3 Japan Tissue Engineering Regenerative Medicine Major Product Offerings
7.23.4 Japan Tissue Engineering Regenerative Medicine Revenue in Global Market (2017-2022)
7.23.5 Japan Tissue Engineering Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Regenerative Medicine Market Opportunities & Trends in Global Market
Table 2. Regenerative Medicine Market Drivers in Global Market
Table 3. Regenerative Medicine Market Restraints in Global Market
Table 4. Key Players of Regenerative Medicine in Global Market
Table 5. Top Regenerative Medicine Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Regenerative Medicine Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Regenerative Medicine Revenue Share by Companies, 2017-2022
Table 8. Global Companies Regenerative Medicine Product Type
Table 9. List of Global Tier 1 Regenerative Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Regenerative Medicine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Regenerative Medicine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Regenerative Medicine Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Regenerative Medicine Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Regenerative Medicine Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Regenerative Medicine Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Regenerative Medicine Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Regenerative Medicine Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Regenerative Medicine Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Regenerative Medicine Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Regenerative Medicine Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Regenerative Medicine Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Regenerative Medicine Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Regenerative Medicine Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Regenerative Medicine Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Regenerative Medicine Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Regenerative Medicine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Regenerative Medicine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Regenerative Medicine Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Regenerative Medicine Revenue, (US$, Mn), 2023-2028
Table 30. J & J (DePuy Synthes) Corporate Summary
Table 31. J & J (DePuy Synthes) Regenerative Medicine Product Offerings
Table 32. J & J (DePuy Synthes) Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 33. Medtronic Corporate Summary
Table 34. Medtronic Regenerative Medicine Product Offerings
Table 35. Medtronic Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 36. Zimmer Biomet Corporate Summary
Table 37. Zimmer Biomet Regenerative Medicine Product Offerings
Table 38. Zimmer Biomet Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 39. Stryker Corporate Summary
Table 40. Stryker Regenerative Medicine Product Offerings
Table 41. Stryker Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 42. Allergan(Acelity) Corporate Summary
Table 43. Allergan(Acelity) Regenerative Medicine Product Offerings
Table 44. Allergan(Acelity) Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 45. MiMedx Group Corporate Summary
Table 46. MiMedx Group Regenerative Medicine Product Offerings
Table 47. MiMedx Group Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 48. Organogenesis Corporate Summary
Table 49. Organogenesis Regenerative Medicine Product Offerings
Table 50. Organogenesis Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 51. Fujifilm Cellular Dynamics Corporate Summary
Table 52. Fujifilm Cellular Dynamics Regenerative Medicine Product Offerings
Table 53. Fujifilm Cellular Dynamics Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 54. Osiris Therapeutics Corporate Summary
Table 55. Osiris Therapeutics Regenerative Medicine Product Offerings
Table 56. Osiris Therapeutics Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 57. Vcanbio Corporate Summary
Table 58. Vcanbio Regenerative Medicine Product Offerings
Table 59. Vcanbio Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 60. CCBC Corporate Summary
Table 61. CCBC Regenerative Medicine Product Offerings
Table 62. CCBC Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 63. Cytori Corporate Summary
Table 64. Cytori Regenerative Medicine Product Offerings
Table 65. Cytori Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 66. Celgene Corporate Summary
Table 67. Celgene Regenerative Medicine Product Offerings
Table 68. Celgene Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 69. Vericel Corporation Corporate Summary
Table 70. Vericel Corporation Regenerative Medicine Product Offerings
Table 71. Vericel Corporation Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 72. Guanhao Biotech Corporate Summary
Table 73. Guanhao Biotech Regenerative Medicine Product Offerings
Table 74. Guanhao Biotech Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 75. Mesoblast Corporate Summary
Table 76. Mesoblast Regenerative Medicine Product Offerings
Table 77. Mesoblast Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 78. AMAG Pharmaceuticals (CBR) Corporate Summary
Table 79. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product Offerings
Table 80. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 81. ViaCord Corporate Summary
Table 82. ViaCord Regenerative Medicine Product Offerings
Table 83. ViaCord Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 84. CordLife Corporate Summary
Table 85. CordLife Regenerative Medicine Product Offerings
Table 86. CordLife Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 87. Integra LifeSciences Corporate Summary
Table 88. Integra LifeSciences Regenerative Medicine Product Offerings
Table 89. Integra LifeSciences Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 90. Nuvasive Corporate Summary
Table 91. Nuvasive Regenerative Medicine Product Offerings
Table 92. Nuvasive Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 93. Cook Biotech Corporate Summary
Table 94. Cook Biotech Regenerative Medicine Product Offerings
Table 95. Cook Biotech Regenerative Medicine Revenue (US$, Mn), (2017-2022)
Table 96. Japan Tissue Engineering Corporate Summary
Table 97. Japan Tissue Engineering Regenerative Medicine Product Offerings
Table 98. Japan Tissue Engineering Regenerative Medicine Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Regenerative Medicine Segment by Type in 2021
Figure 2. Regenerative Medicine Segment by Application in 2021
Figure 3. Global Regenerative Medicine Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Regenerative Medicine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Regenerative Medicine Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Regenerative Medicine Revenue in 2021
Figure 8. By Type - Global Regenerative Medicine Revenue Market Share, 2017-2028
Figure 9. By Application - Global Regenerative Medicine Revenue Market Share, 2017-2028
Figure 10. By Region - Global Regenerative Medicine Revenue Market Share, 2017-2028
Figure 11. By Country - North America Regenerative Medicine Revenue Market Share, 2017-2028
Figure 12. US Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Regenerative Medicine Revenue Market Share, 2017-2028
Figure 16. Germany Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 17. France Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Regenerative Medicine Revenue Market Share, 2017-2028
Figure 24. China Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 28. India Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Regenerative Medicine Revenue Market Share, 2017-2028
Figure 30. Brazil Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Regenerative Medicine Revenue Market Share, 2017-2028
Figure 33. Turkey Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Regenerative Medicine Revenue, (US$, Mn), 2017-2028
Figure 37. J & J (DePuy Synthes) Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Medtronic Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Zimmer Biomet Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Stryker Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Allergan(Acelity) Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. MiMedx Group Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Organogenesis Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Fujifilm Cellular Dynamics Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Osiris Therapeutics Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Vcanbio Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. CCBC Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Cytori Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Celgene Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Vericel Corporation Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Guanhao Biotech Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Mesoblast Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. ViaCord Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. CordLife Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Integra LifeSciences Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Nuvasive Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Cook Biotech Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 59. Japan Tissue Engineering Regenerative Medicine Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Global Tissue Engineered Skin Substitutes Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global Tissue Engineered Skin Substitutes market was valued at US$ 1571.8 million in 2023 and is anticipated to reach US$ 3109.6 million by 2030, witnessing a CAGR of 9.8% during The forecast period 2024-2030.
North American market for Tissue Engineered Skin Substitutes is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Tissue Engineered Skin Substitutes is est......
Global Tissue Engineering Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 134
According to our LPI (LP Information) latest study, the global Tissue Engineering market size was valued at US$ 26430 million in 2023. With growing demand in downstream market, the Tissue Engineering is forecast to a readjusted size of US$ 90330 million by 2030 with a CAGR of 19.2% during review period.
The research report highlights the growth potential of the global Tissue Engineering market. Tissue Engineering are expected to show stable growth in the future market. However, product d......
Global Regenerative Medicine Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 150
According to our LPI (LP Information) latest study, the global Regenerative Medicine market size was valued at US$ 32640 million in 2023. With growing demand in downstream market, the Regenerative Medicine is forecast to a readjusted size of US$ 116410 million by 2030 with a CAGR of 19.9% during review period.
The research report highlights the growth potential of the global Regenerative Medicine market. Regenerative Medicine are expected to show stable growth in the future market. Howev......
Global Tissue Engineered Skin Substitutes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 108
Market Overview of Global Tissue Engineered Skin Substitutes market:
According to our latest research, the global Tissue Engineered Skin Substitutes market looks promising in the next 5 years. As of 2022, the global Tissue Engineered Skin Substitutes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Tissue-engineered skin substitutes have become viable as a suitable alternative to auto- ......
Regenerative Medicine Products - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 121
The global Regenerative Medicine Products market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Regenerative Medicine Products in various end use industries. The expanding demands from the Dermatology, Cardiovascular, CNS and Orthopedic, are propelling Regenerative Medicine Products market. Cell Therapy, one of the segments analysed in this report, is projected to record % CAGR and reach US$ ......
Tissue Engineered Skin Substitutes - Global Market Insights and Sales Trends 2024
Published: 21-Dec-2023 Price: US 3350 Onwards Pages: 96
The global Tissue Engineered Skin Substitutes market size is expected to reach US$ 3109.6 million by 2029, growing at a CAGR of 9.8% from 2023 to 2029. The market is mainly driven by the significant applications of Tissue Engineered Skin Substitutes in various end use industries. The expanding demands from the Burn Injury, Diabetic, Vascular Ulcer and Others, are propelling Tissue Engineered Skin Substitutes market. Acellular, one of the segments analysed in this report, is projected to record %......
Global Tissue Engineering and Regeneration Market Research Report 2023
Published: 21-Nov-2023 Price: US 2900 Onwards Pages: 98
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Tissue Engineering and Regeneration market with multiple angles, which provides sufficient supports to readers' strategy and decision making.
By Company
- Advanced Cell Technology
- Ocata Therapeutics
- Arteriocyte
- Therapeutics
- BioTissue Technologies
- Kinetic Concepts
- Bi......
Global Tissue Analysis Products Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 09-Nov-2023 Price: US 3380 Onwards Pages: 103
Market Overview of Global Tissue Analysis Products market:
According to our latest research, the global Tissue Analysis Products market looks promising in the next 5 years. As of 2022, the global Tissue Analysis Products market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global......
Regenerative Medicine Collaboration and Licensing Deals 2016-2023
Published: 01-Nov-2023 Price: US 3995 Onwards Pages: 950
Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the regenerative medicine deals entered into by the worlds leading biopharma companies.
Fully revised and updated, the report provides details of regenerative medicine deals from 2016 to 2023.
The report provides a detailed understanding and analysis of how and why companies enter regenerative medicine deals. These deals tend to be multicomponent, s......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
